Inactive Instrument

OWC Pharmaceutical Research Corp. Share Price Other OTC

Equities

OWCP

US67109N1081

Advanced Medical Equipment & Technology

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2017 - Sales 2018 - Capitalization 1.54Cr 128.24Cr
Net income 2017 -40L -33Cr Net income 2018 -1Cr -83Cr EV / Sales 2017 -
Net cash position 2017 10L 8.1Cr Net cash position 2018 34.64L 29Cr EV / Sales 2018 -
P/E ratio 2017
-14.5 x
P/E ratio 2018
-1.21 x
Employees -
Yield 2017 *
-
Yield 2018
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 52 21/20/21
Director of Finance/CFO 57 16/14/16
Chief Tech/Sci/R&D Officer 67 02/16/02
Members of the board TitleAgeSince
Director of Finance/CFO 57 25/20/25
Chief Executive Officer 52 21/20/21
Director/Board Member 69 -
More insiders
OWC Pharmaceutical Research Corp. is a medical cannabis research and development company. The Company is engaged in the research and development of cannabis-based medical products (the Product Prospects) for the treatment of multiple myeloma, psoriasis and fibromyalgia, as well as development of a cannabis soluble tablet delivery system that has applications for other indications. The Company also provides consulting services to governmental and private entities to assist them with developing and implementing various medical cannabis programs. As of September 30, 2016, the Company was engaged in two business activities: work with GUMI to commercialize and market the Company's Electromagnetic Percussion Device (the Device), and research and development of Cannabis-based medical products for the treatment of a range of medical conditions and/or diseases, such as multiple myeloma, psoriasis, post-traumatic stress disorder (PTSD) migraines and a delivery system.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW